Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
about
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancerTherapeutic options for HER-2 positive breast cancer: Perspectives and future directionsAnalysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.Expression of eag1 channel associated with the aggressive clinicopathological features and subtype of breast cancer.Neurotoxicity of biologically targeted agents in pediatric cancer trials
P2860
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@ast
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@en
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@nl
type
label
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@ast
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@en
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@nl
prefLabel
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@ast
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@en
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
@nl
P2093
P2860
P1476
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer
@en
P2093
Catherine Oakman
Egidia Cantisani
Elena Zafarana
Marta Pestrin
P2860
P407
P577
2010-01-07T00:00:00Z